These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7189285)

  • 1. Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity.
    Wilcox RE; Smith RV; Anderson JA; Riffee WH
    Pharmacol Biochem Behav; 1980 Jan; 12(1):29-33. PubMed ID: 7189285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral demonstration of a reciprocal interaction between dopamine receptor subtypes in the mouse striatum: possible involvement of the striato-nigral pathway.
    Mandel RJ; Yurek DM; Randall PK
    Brain Res Bull; 1990 Aug; 25(2):285-92. PubMed ID: 2146002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.
    Dewey KJ; Fibiger HC
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):261-70. PubMed ID: 6683359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of fluphenazine-N-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice.
    Thermos K; Winkler JD; Weiss B
    Neuropharmacology; 1987 Oct; 26(10):1473-80. PubMed ID: 3120028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice.
    Riffee WH; Wilcox RE; Smith RV
    Eur J Pharmacol; 1979 Mar; 54(3):273-7. PubMed ID: 570924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia.
    Moore NA; Axton MS
    Eur J Pharmacol; 1990 Mar; 178(2):195-201. PubMed ID: 2184043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum.
    Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1976 Oct; 50(1):1-6. PubMed ID: 827755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C; De Lucia R; Bernardi MM; Aizenstein ML
    Eur J Pharmacol; 1985 May; 112(1):11-6. PubMed ID: 4040467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased sensitivity to dopamine agonists following a single dose of morphine or levorphanol in mice.
    Martin JR; Takemori AE
    Eur J Pharmacol; 1985 Dec; 119(1-2):75-84. PubMed ID: 3002820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
    Mandel RJ; Wilcox RE; Randall PK
    Pharmacol Biochem Behav; 1992 Feb; 41(2):343-7. PubMed ID: 1574523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
    Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gradual score to evaluate the climbing behaviour elicited by apomorphine in mice.
    Marcais H; Protais P; Costentin J; Schwartz JC
    Psychopharmacology (Berl); 1978 Mar; 56(2):233-4. PubMed ID: 417378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine.
    Lee JM; DeLeon-Jones F; Fields JZ; Ritzmann RF
    Alcohol Drug Res; 1987; 7(1):1-10. PubMed ID: 2431697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz
    Acta Physiol Pol; 1980; 31(2):153-8. PubMed ID: 6771963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral facilitation following chronic administration of N-n-propylnorapomorphine.
    Wilcox RE; Riffee WH; Chen PC; Hammett S; Smith RV
    Psychopharmacology (Berl); 1980; 72(1):113-5. PubMed ID: 6781003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.